ArticleAging2020

Zinc oxide nanoparticles (ZnO NPs) combined with cisplatin and gemcitabine inhibits tumor activity of NSCLC cells.

Chenping Hu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.